Fundz

Arthrosi, a San Diego-based biotechnology company, raised $153M in Series E funding led by Prime Eight Capital to expand operations and development efforts.

RECENTLY ACQUIREDOct 08, 2025

Amount Raised

$153 Million

Round Type

Series E

Laguna HillsManufacturingBiotechnologyHealthcare

Investors

Highlight CapitalReliantTech LimitedCr BiotechHm Venture PartnersPrime Eight Capital Limited

Description

Arthrosi raised $153M in Series E funding to support its development of URAT1 inhibitors. The round was led by Prime Eight Capital with participation from several investors. The company is focused on advancing pozdeutinurad in a pivotal Phase 3 program. This funding will help to expand operations and enhance development efforts.

Quick answer

Arthrosi Therapeutics raised $153 Million in a Series E round, dated October 8, 2025. Investors: Highlight Capital, ReliantTech Limited, Cr Biotech, Hm Venture Partners and Prime Eight Capital Limited. Arthrosi Therapeutics is based in Laguna Hills, California, United States.

How much did Arthrosi Therapeutics raise?
Arthrosi Therapeutics raised $153 Million in a Series E round on October 8, 2025.
Who invested in Arthrosi Therapeutics?
Highlight Capital, ReliantTech Limited, Cr Biotech, Hm Venture Partners and Prime Eight Capital Limited are named as investors in this round.
What does Arthrosi Therapeutics do?
Arthrosi Therapeutics, Inc., headquartered in San Diego, CA, is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels,..
Where is Arthrosi Therapeutics based and how big is it?
Arthrosi Therapeutics is based in Laguna Hills, California, United States. Fundz records about 39 employees.
Who are the decision-makers at Arthrosi Therapeutics?
Fundz holds 1 contact at Arthrosi Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Manufacturing around the same time

Companies in the same sectors as Arthrosi Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Allurion Technologies raised $5M (Private Equity) on November 11, 2025.
  • Tenon Medical raised $2.9M (Funding Round) on November 11, 2025.
  • Spineology raised $8.8M on November 7, 2025.
  • RedHill Biopharma Ltd raised $4M (Corporate Round) on October 20, 2025.
  • Talphera, Inc. raised $17M on September 10, 2025.
  • Rubi Laboratories raised $7.5M on November 21, 2025.

Who to call at Arthrosi Therapeutics, and when

A new round usually means Arthrosi Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arthrosi Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arthrosi Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arthrosi Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arthrosi Therapeutics

Location

9855 Towne Centre Dr, #200

Laguna Hills, California, United States

About

Arthrosi Therapeutics, Inc., headquartered in San Diego, CA, is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients with progressive gout. The rights to pozdeutinurad in Greater China are held by ApicHope.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arthrosi Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts29 people are listed at Arthrosi Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Arthrosi Therapeutics's next move

See what Strategic adds

Arthrosi Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.